Literature DB >> 30262245

Comprehensive analysis of antibody responses to Plasmodium falciparum erythrocyte membrane protein 1 domains.

Bernard N Kanoi1, Hikaru Nagaoka1, Masayuki Morita1, Michael T White2, Nirianne M Q Palacpac3, Edward H Ntege1, Betty Balikagala1, Adoke Yeka4, Thomas G Egwang5, Toshihiro Horii3, Takafumi Tsuboi6, Eizo Takashima7.   

Abstract

Acquired antibodies directed towards antigens expressed on the surface of merozoites and infected erythrocytes play an important role in protective immunity to Plasmodium falciparum malaria. P. falciparum erythrocyte membrane protein 1 (PfEMP1), the major parasite component of the infected erythrocyte surface, has been implicated in malaria pathology, parasite sequestration and host immune evasion. However, the extent to which unique PfEMP1 domains interact with host immune response remains largely unknown. In this study, we sought to comprehensively understand the naturally acquired antibody responses targeting different Duffy binding-like (DBL), and Cysteine-rich interdomain region (CIDR) domains in a Ugandan cohort. Consequently, we created a protein library consisting of full-length DBL (n = 163) and CIDR (n = 108) domains derived from 62-var genes based on 3D7 genome. The proteins were expressed by a wheat germ cell-free system; a system that yields plasmodial proteins that are comparatively soluble, intact, biologically active and immunoreactive to human sera. Our findings suggest that all PfEMP1 DBL and CIDR domains, regardless of PfEMP1 group, are targets of naturally acquired immunity. The breadth of the immune response expands with children's age. We concurrently identified 10 DBL and 8 CIDR domains whose antibody responses were associated with reduced risk to symptomatic malaria in the Ugandan children cohort. This study highlights that only a restricted set of specific domains are essential for eliciting naturally acquired protective immunity in malaria. In light of current data, tandem domains in PfEMP1s PF3D7_0700100 and PF3D7_0425800 (DC4) are recommended for extensive evaluation in larger population cohorts to further assess their potential as alternative targets for malaria vaccine development.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Malaria; Naturally acquired immunity; PfEMP1; Plasmodium falciparum; Uganda; Vaccine

Mesh:

Substances:

Year:  2018        PMID: 30262245     DOI: 10.1016/j.vaccine.2018.08.058

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Meta-Analysis of Human Antibodies Against Plasmodium falciparum Variable Surface and Merozoite Stage Antigens.

Authors:  Eizo Takashima; Bernard N Kanoi; Hikaru Nagaoka; Masayuki Morita; Ifra Hassan; Nirianne M Q Palacpac; Thomas G Egwang; Toshihiro Horii; Jesse Gitaka; Takafumi Tsuboi
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

2.  Identifying Targets of Protective Antibodies against Severe Malaria in Papua, Indonesia, Using Locally Expressed Domains of Plasmodium falciparum Erythrocyte Membrane Protein 1.

Authors:  Janavi S Rambhatla; Gerry Q Tonkin-Hill; Eizo Takashima; Takafumi Tsuboi; Rintis Noviyanti; Leily Trianty; Boni F Sebayang; Daniel A Lampah; Jutta Marfurt; Ric N Price; Nicholas M Anstey; Anthony T Papenfuss; Timon Damelang; Amy W Chung; Michael F Duffy; Stephen J Rogerson
Journal:  Infect Immun       Date:  2021-12-06       Impact factor: 3.609

3.  Global Repertoire of Human Antibodies Against Plasmodium falciparum RIFINs, SURFINs, and STEVORs in a Malaria Exposed Population.

Authors:  Bernard N Kanoi; Hikaru Nagaoka; Michael T White; Masayuki Morita; Nirianne M Q Palacpac; Edward H Ntege; Betty Balikagala; Adoke Yeka; Thomas G Egwang; Toshihiro Horii; Takafumi Tsuboi; Eizo Takashima
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

Review 4.  Malaria-induced bacteremia as a consequence of multiple parasite survival strategies.

Authors:  Erinn Donnelly; Judy Van de Water; Shirley Luckhart
Journal:  Curr Res Microb Sci       Date:  2021-05-08

Review 5.  Identification of Novel Malaria Transmission-Blocking Vaccine Candidates.

Authors:  Eizo Takashima; Mayumi Tachibana; Masayuki Morita; Hikaru Nagaoka; Bernard N Kanoi; Takafumi Tsuboi
Journal:  Front Cell Infect Microbiol       Date:  2021-11-30       Impact factor: 5.293

6.  Recombinant DBL2β-PfEMP1 of the Indonesian Plasmodium falciparum induces immune responses in Wistar rats.

Authors:  Sheilla Rachmania; Erma Sulistyaningsih; Anak Agung I Ratna Dewi
Journal:  J Taibah Univ Med Sci       Date:  2021-01-15

Review 7.  Malaria vaccines: facing unknowns.

Authors:  Nirianne Marie Q Palacpac; Toshihiro Horii
Journal:  F1000Res       Date:  2020-04-27

Review 8.  Naturally Acquired Humoral Immunity Against Plasmodium falciparum Malaria.

Authors:  S Jake Gonzales; Raphael A Reyes; Ashley E Braddom; Gayani Batugedara; Sebastiaan Bol; Evelien M Bunnik
Journal:  Front Immunol       Date:  2020-10-29       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.